XML 32 R17.htm IDEA: XBRL DOCUMENT
v3.21.1

Borrowings | 3 Months Ended
--- | ---
Mar. 31, 2021
Borrowings [Abstract] |
Borrowings | Note 11 – Borrowings Our Company’s borrowings at March 31, 2021 and December 31, 2020, net of deferred financing costs and including the impact of interest rate derivatives on effective interest rates, are summarized below:
|  | As of March 31, 2021
(Dollars in thousands) |  | Maturity Date |  | Contractual ‎Facility |  | Balance, ‎Gross |  | Balance, ‎Net(1) |  | Stated ‎Interest Rate |  | Effective ‎Interest ‎Rate
Denominated in USD |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Trust Preferred Securities (USA) |  | April 30, 2027 |  | $ | 27,913 |  | $ | 27,913 |  | $ | 26,561 |  | 4.21% |  | 4.21%
Bank of America Credit Facility (USA) |  | March 6, 2023 |  |  | 55,000 |  |  | 49,900 |  |  | 49,690 |  | 4.00% |  | 4.00%
Bank of America Line of Credit (USA) |  | March 6, 2023 |  |  | 5,000 |  |  | 5,000 |  |  | 5,000 |  | 3.11% |  | 3.11%
Cinemas 1, 2, 3 Term Loan (USA) |  | April 1, 2022 |  |  | 24,477 |  |  | 24,477 |  |  | 24,106 |  | 4.25% |  | 4.25%
Minetta & Orpheum Theatres Loan (USA)(2) |  | November 1, 2023 |  |  | 8,000 |  |  | 8,000 |  |  | 7,922 |  | 2.17% |  | 5.15%
U.S. Corporate Office Term Loan (USA) |  | January 1, 2027 |  |  | 9,124 |  |  | 9,124 |  |  | 9,037 |  | 4.64% / 4.44% |  | 4.61%
Purchase Money Promissory Note (USA) |  | September 18, 2024 |  |  | 2,553 |  |  | 2,553 |  |  | 2,553 |  | 5.00% |  | 5.00%
Denominated in foreign currency ("FC") (3) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
NAB Corporate Term Loan (AU) |  | December 31, 2023 |  |  | 93,640 |  |  | 93,640 |  |  | 93,454 |  | 1.81% |  | 1.81%
Westpac Bank Corporate (NZ) |  | December 31, 2023 |  |  | 22,365 |  |  | 22,365 |  |  | 22,365 |  | 2.95% |  | 2.95%
|  |  |  | $ | 248,072 |  | $ | 242,972 |  | $ | 240,688 |  |  |  |
(1)Net of deferred financing costs amounting to $2.3 million. (2)The interest rate derivative associated with the Minetta & Orpheum loan provides for an effective fixed rate of 5.15%. (3)The contractual facilities and outstanding balances of the foreign currency denominated borrowings were translated into U.S. dollars based on the applicable exchange rates as of March 31, 2021.
|  | As of December 31, 2020
(Dollars in thousands) |  | Maturity Date |  | Contractual ‎Facility |  | Balance, ‎Gross |  | Balance, Net(1) |  | Stated ‎Interest ‎Rate |  | Effective Interest Rate
Denominated in USD |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Trust Preferred Securities (USA) |  | April 30, 2027 |  | $ | 27,913 |  | $ | 27,913 |  | $ | 26,505 |  | 4.27% |  | 4.27%
Bank of America Credit Facility (USA) |  | March 6, 2023 |  |  | 55,000 |  |  | 51,200 |  |  | 50,990 |  | 4.00% |  | 4.00%
Bank of America Line of Credit (USA) |  | March 6, 2023 |  |  | 5,000 |  |  | 5,000 |  |  | 5,000 |  | 3.15% |  | 3.15%
Cinemas 1, 2, 3 Term Loan (USA) |  | April 1, 2022 |  |  | 24,625 |  |  | 24,625 |  |  | 24,248 |  | 4.25% |  | 4.25%
Minetta & Orpheum Theatres Loan (USA)(2) |  | November 1, 2023 |  |  | 8,000 |  |  | 8,000 |  |  | 7,914 |  | 2.20% |  | 5.15%
U.S. Corporate Office Term Loan (USA) |  | January 1, 2027 |  |  | 9,186 |  |  | 9,186 |  |  | 9,095 |  | 4.64% / 4.44% |  | 4.64%
Union Square Construction Financing (USA) |  | March 31, 2021 |  |  | 50,000 |  |  | 40,623 |  |  | 40,620 |  | 17.50% |  | 17.50%
Purchase Money Promissory Note |  | September 18, 2024 |  |  | 2,883 |  |  | 2,883 |  |  | 2,883 |  | 5.00% |  | 5.00%
Denominated in foreign currency ("FC")(3) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
NAB Corporate Term Loan (AU) |  | December 31, 2023 |  |  | 94,821 |  |  | 92,508 |  |  | 92,307 |  | 1.81% |  | 1.81%
Westpac Bank Corporate (NZ) |  | December 31, 2023 |  |  | 23,021 |  |  | 23,021 |  |  | 23,021 |  | 2.95% |  | 2.95%
Total |  |  |  | $ | 300,449 |  | $ | 284,959 |  | $ | 282,583 |  |  |  |
(1)Net of deferred financing costs amounting to $2.4 million. (2)The interest rate derivative associated with the Minetta & Orpheum loan provides for an effective fixed rate of 5.15%. (3)The contractual facilities and outstanding balances of the foreign currency denominated borrowings were translated into U.S. dollars based on the applicable exchange rates as of December 31, 2020. Our loan arrangements are presented, net of the deferred financing costs, on the face of our consolidated balance sheet as follows:
|  | March 31, |  | December 31,
Balance Sheet Caption |  | 2021 |  | 2020
Debt - current portion |  | $ | 1,606 |  | $ | 41,459
Debt - long-term portion |  |  | 211,836 |  |  | 213,779
Subordinated debt - current portion |  |  | 685 |  |  | 840
Subordinated debt - long-term portion |  |  | 26,561 |  |  | 26,505
Total borrowings |  | $ | 240,688 |  | $ | 282,583
Impact of COVID-19 To address the impact of COVID-19 on our business, we sought and obtained certain modifications to our loan agreements with the Bank of America, National Australia Bank, and Westpac. These loan modifications included changes to some of the covenant compliance terms and waivers of certain covenant testing periods. We are currently in compliance with our loan covenants as so modified. To date it has not been necessary for us to seek modifications or waivers with respect to our other loan agreements, as we continue to be in compliance with the terms of such loan agreements without the need for any such modifications or waivers. Bank of America Credit Facility On March 6, 2020, we amended our $55.0 million credit facility with Bank of America extending the maturity date to March 6, 2023. The refinanced facility carries an interest rate of 2.5% - 3.0%, depending on certain financial ratios plus a variable rate based on the loan defined “Eurodollar” interest rate. On August 7, 2020, we modified certain financial covenants within this credit facility and temporarily suspended the testing of certain other covenant tests through the measurement period ending September 30, 2021. The testing of the financial covenant resumes for the measurement period ending December 31, 2021. In addition to the covenant modifications, the interest rate on borrowings under this facility was fixed at 3.0% above the “Eurodollar” rate, which itself now has a floor of 1.0%. Such a modification was not considered to be substantial under U.S. GAAP. Bank of America Line of Credit On March 6, 2020, the term of our $5.0 million line of credit was extended to March 6, 2023. On August 7, 2020 we modified the interest rate on this line of credit, wherein the LIBOR portion of the rate now has a floor of 1.0%. Minetta and Orpheum Theatres Loan On October 12, 2018, we refinanced our $7.5 million loan with Santander Bank, which is secured by our Minetta and Orpheum Theatres, with a loan for a five year term of $8.0 million. Such modification was not considered to be substantial under U.S. GAAP. U.S. Corporate Office Term Loan On December 13, 2016, we obtained a ten year $8.4 million mortgage loan on our Culver City Corporate Headquarters at a fixed annual interest rate of 4.64%. This loan provided for a second loan upon completion of certain improvements. On June 26, 2017, we obtained a further $1.5 million under this provision at a fixed annual interest rate of 4.44%. Cinemas 1,2,3 Term Loan On March 13, 2020, Sutton Hill Properties LLC (“SHP”), a 75% subsidiary of RDI, refinanced its $20.0 million term loan with Valley National Bank with a new term loan of $25.0 million, an interest rate of 4.25%, and maturity date of April 1, 2022 with two six month options to extend. Union Square Construction Financing On December 29, 2016, we closed our construction finance facilities totaling $57.5 million to fund the non-equity portion of the anticipated construction costs of the redevelopment of our property at 44 Union Square in New York City. The facilities consisted of a first mortgage component of $50.0 million and a mezzanine component of $7.5 million. On August 8, 2019, we repaid the $7.5 million mezzanine loan. On January 24, 2020, we exercised the first of our two one year extension options on the first mortgage loan, taking the maturity to December 29, 2020. On December 29, 2020, we further extended the maturity of this loan to March 31, 2021, at an interest rate of 17.5%. On March 26, 2021, we repaid this first mortgage loan using internally generated funds. As of March 31, 2021, 44 Union Square is unencumbered by debt financing. On May 7, 2021, we closed on a new three year $55.0 million loan facility with Emerald Creek Capital. The facility bears a variable interest rate of one month LIBOR plus 6.9% with a floor of 7.0%, and has two 12-month options to extend, but may be repaid at any time, subject to notice and a minimum interest payment equal to the positive difference between interest paid on the loan through the pre-payment date and one year’s interest. In effect, the loan may be repaid after 12 months without the payment of any premium. Purchase Money Promissory Note On September 18, 2019, we purchased for $5.5 million 407,000 Company Class A Common Stock in a privately negotiated transaction under our Share Repurchase Program. Of this amount, $3.5 million was paid by the issuance of a Purchase Money Promissory Note, which bears an interest rate of 5.0% per annum, payable in equal quarterly payments of principal plus accrued interest. The Purchase Money Promissory Note matures on September 18, 2024. Westpac Bank Corporate Credit Facility (NZ) On December 20, 2018, we restructured our Westpac Corporate Credit Facilities. The maturity of the 1 st tranche (general/non-construction credit line) was extended to December 31, 2023, with the available facility being reduced from NZ$35.0 million to NZ$32.0 million. The facility bears an interest rate of 1.75% above the Bank Bill Bid Rate on the drawn down balance and a 1.1% line of credit charge on the entire facility. The 2 nd tranche (construction line) with a facility of NZ$18.0 million was removed. On June 29, 2020, Westpac pushed out the June 30, 2020 covenant testing date to July 31, 2020. On July 27, 2020, Westpac waived the requirement to test certain covenants as of July 31, 2020. This agreement also increased the interest rate and line of credit charge to 2.40% above the Bank Bill Bid Rate and 1.65% respectively. The maturity date was extended to January 1, 2024. Such modifications of this facility were not considered to be substantial under U.S. GAAP. On September 15, 2020, Westpac waived the requirement to test certain covenants as of September 30, 2020. On December 8, 2020, Westpac waived the requirement to test certain covenants as of December 31, 2020. On April 29, 2021, Westpac waived the requirement to test certain covenants as of March 31, 2021. On May 7, 2021, we repaid $11.2 million (NZ$16.0 million) of this debt, in a permanent reduction of this facility. Australian NAB Corporate Term Loan (AU) On March 15, 2019, we amended our Revolving Corporate Markets Loan Facility with National Australia Bank (“NAB”) from a facility comprised of (i) a AU$66.5 million loan facility with an interest rate of 0.95% above the Bank Bill Swap Bid Rate (“BBSY”) and a maturity date of June 30, 2019 and (ii) a bank guarantee of AU$5.0 million at a rate of 1.90% per annum into a (i) AU$120.0 million Corporate Loan facility at rates of 0.85%-1.30% above BBSY depending on certain ratios with a due date of December 31, 2023, of which AU$80.0 million is revolving and AU$40.0 million is core and (ii) a Bank Guarantee Facility of AU$5.0 million at a rate of 1.85% per annum. Such modifications of this particular term loan were not considered to be substantial under U.S. GAAP. On August 6, 2020, we modified certain covenants within this Revolving Corporate Markets Loan Facility. These modifications apply until the quarter ended September 30, 2021. In addition, for the period in which these covenant modifications apply, the interest rate on amounts borrowed under the facility is 1.75%. Such a modification was not considered to be substantial under U.S. GAAP. On December 29, 2020, we modified the core portion of our Revolving Corporate Markets Loan Facility, increasing it to AU$43.0 million. The AU$3.0 million increase was provided to fund the completion of our recently opened cinema at Jindalee, Queensland, and is repayable in installments by October 31, 2023. This amendment increases the Facility Limit to AU$123.0 million, which will be reduced back to AU $120.0 million as the Jindalee funding is repaid.

X
- References No definition available. + Details
Name: | us-gaap_DebtDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -URI http://asc.fasb.org/topic&trid=2208564 + Details
Name: | us-gaap_DebtDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration